News Samsung Biologics Co.,Ltd.

Equities

A207940

KR7207940008

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-14 pm EDT			5-day change	1st Jan Change
793,000 ^KRW	+0.38%		-2.70%	+4.34%

Apr. 08	Samsung Biologics Boosts Contract Size with MSD Switzerland	MT
Mar. 20	Samsung Life Science Fund Invests in Biologics Developer	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Samsung Biologics Boosts Contract Size with MSD Switzerland	Apr. 08	MT
Samsung Life Science Fund Invests in BrickBio	Mar. 20	AQ
Samsung Life Science Fund Invests in Biologics Developer	Mar. 20	MT
CEO IR Newsletter : 2024 AGM Wrap Up	Mar. 14	PU
Samsung Biologics : hosts 13th Annual General Meeting of Shareholders	Mar. 14	PU
Samsung Group Initiates Open Hiring Drive for New Talent Acquisition	Mar. 12	MT
South Korean Shares Close Higher After US Fed Chief Hints at Rate Cuts; Samsung Biologics Adds 1%	Mar. 07	MT
Samsung Biologics Strikes $353 Million Deal with Belgium's UCB	Mar. 07	MT
Samsung Biologics signs MOU with Seoul National University to foster bio experts	Mar. 01	AQ
South Korean Shares Dip on Tech, Pharma Losses; Celltrion Sheds 5% on Lackluster Q4 Earnings	Feb. 29	MT
Samsung Biologics Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Samsung Biologics awarded Leadership status by CDP for climate action efforts	Feb. 14	AQ
Samsung Biologics Collaborates with LegoChem Biosciences on ADC Development and Manufacturing	Feb. 09	MT
Samsung Biologics partners with LegoChem Biosciences for ADC development and manufacturing	Feb. 08	AQ
Samsung chair found not guilty of charges connected to 2015 merger	Feb. 05	AQ
Samsung chief Lee Jae-yong is acquitted of financial crimes related to 2015 merger	Feb. 05	AQ
Samsung chief acquitted in controversial 2015 merger case	Feb. 05	AQ
Samsung C&T to invest in future growth and enhance shareholder value on foundation of steady performance	Feb. 01	AQ
Samsung Biologics's Q4 Net Income Declines	Jan. 24	MT
Samsung Biologics receives EcoVadis Platinum, the highest sustainability rating	Jan. 23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Samsung Biologics Co.,Ltd.

Equities

A207940

KR7207940008

Summary

Filters